Organon (OGN) Ratios
Organon Ratios
MX:OGN's free cash flow for Q3 2026 was $326.00M. For the 2026 fiscal year, MX:OGN's free cash flow was decreased by $-44.00M and operating cash flow was $370.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.82 | 1.60 | 1.54 | 1.56 | 1.45 |
| Quick Ratio | 1.23 | 1.11 | 1.09 | 1.17 | 1.10 |
| Cash Ratio | 0.24 | 0.25 | 0.24 | 0.28 | 0.28 |
| Solvency Ratio | 0.05 | 0.09 | 0.10 | 0.10 | 0.13 |
| Operating Cash Flow Ratio | 0.29 | 0.35 | 0.27 | 0.34 | 0.95 |
| Short-Term Operating Cash Flow Coverage | 12.50 | 14.67 | 14.53 | 15.05 | 44.69 |
| Net Current Asset Value | $ -7.76B | $ -8.28B | $ -7.62B | $ -7.92B | $ -8.43B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.68 | 0.69 | 0.74 | 0.83 | 0.88 |
| Debt-to-Equity Ratio | 11.70 | 19.14 | -127.59 | -10.22 | -6.21 |
| Debt-to-Capital Ratio | 0.92 | 0.95 | 1.01 | 1.11 | 1.19 |
| Long-Term Debt-to-Capital Ratio | 0.92 | 0.95 | 1.01 | 1.11 | 1.20 |
| Financial Leverage Ratio | 17.11 | 27.76 | -172.26 | -12.28 | -7.08 |
| Debt Service Coverage Ratio | 1.88 | 2.84 | 3.07 | 3.24 | 5.76 |
| Interest Coverage Ratio | 2.55 | 2.86 | 2.52 | 4.04 | 7.42 |
| Debt to Market Cap | 4.67 | 2.33 | 2.39 | 1.26 | 1.19 |
| Interest Debt Per Share | 35.85 | 37.18 | 37.06 | 37.52 | 37.95 |
| Net Debt to EBITDA | 6.38 | 5.21 | 5.74 | 4.79 | 4.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 54.09% | 58.02% | 59.84% | 62.84% | 62.21% |
| EBIT Margin | 14.95% | 20.72% | 19.16% | 25.01% | 28.35% |
| EBITDA Margin | 20.75% | 25.05% | 22.93% | 28.44% | 31.44% |
| Operating Profit Margin | 20.67% | 23.21% | 21.19% | 27.62% | 30.38% |
| Pretax Profit Margin | 6.84% | 12.60% | 10.75% | 18.17% | 24.25% |
| Net Profit Margin | 3.01% | 13.49% | 16.33% | 14.85% | 21.43% |
| Continuous Operations Profit Margin | 3.01% | 13.49% | 16.33% | 14.85% | 21.43% |
| Net Income Per EBT | 44.00% | 107.06% | 152.01% | 81.73% | 88.36% |
| EBT Per EBIT | 33.07% | 54.31% | 50.72% | 65.81% | 79.84% |
| Return on Assets (ROA) | 1.45% | 6.59% | 8.48% | 8.37% | 12.65% |
| Return on Equity (ROE) | 24.87% | 183.05% | -1461.43% | -102.80% | -89.59% |
| Return on Capital Employed (ROCE) | 12.26% | 14.31% | 14.52% | 20.19% | 23.69% |
| Return on Invested Capital (ROIC) | 5.37% | 14.22% | 14.43% | 16.39% | 20.79% |
| Return on Tangible Assets | 2.47% | 12.33% | 14.78% | 16.08% | 24.89% |
| Earnings Yield | 10.05% | 22.53% | 27.79% | 12.92% | 17.50% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.34 | 4.29 | 3.37 | 3.84 | 4.17 |
| Payables Turnover | 3.00 | 2.33 | 1.91 | 2.03 | 1.72 |
| Inventory Turnover | 2.03 | 2.03 | 1.91 | 2.29 | 2.60 |
| Fixed Asset Turnover | 4.77 | 4.83 | 4.62 | 5.01 | 5.24 |
| Asset Turnover | 0.48 | 0.49 | 0.52 | 0.56 | 0.59 |
| Working Capital Turnover Ratio | 3.46 | 3.98 | 4.16 | 4.78 | 6.13 |
| Cash Conversion Cycle | 142.21 | 107.81 | 108.37 | 74.42 | 15.98 |
| Days of Sales Outstanding | 84.14 | 84.99 | 108.22 | 94.94 | 87.54 |
| Days of Inventory Outstanding | 179.81 | 179.38 | 190.84 | 159.59 | 140.21 |
| Days of Payables Outstanding | 121.75 | 156.56 | 190.70 | 180.11 | 211.77 |
| Operating Cycle | 263.96 | 264.37 | 299.07 | 254.53 | 227.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.70 | 3.65 | 3.13 | 3.38 | 9.69 |
| Free Cash Flow Per Share | 2.07 | 2.29 | 2.11 | 1.70 | 7.77 |
| Dividend Paid and CapEx Coverage Ratio | 2.80 | 1.45 | 1.44 | 1.20 | 3.88 |
| Capital Expenditure Coverage Ratio | 4.32 | 2.68 | 3.06 | 2.01 | 5.04 |
| Operating Cash Flow Coverage Ratio | 0.08 | 0.10 | 0.09 | 0.09 | 0.26 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.15 | 0.13 | 0.14 | 0.39 |
| Free Cash Flow Yield | 28.92% | 15.33% | 14.62% | 6.07% | 25.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.96 | 4.44 | 3.60 | 7.74 | 5.71 |
| Price-to-Sales (P/S) Ratio | 0.30 | 0.60 | 0.59 | 1.15 | 1.22 |
| Price-to-Book (P/B) Ratio | 2.47 | 8.13 | -52.58 | -7.96 | -5.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.46 | 6.52 | 6.84 | 16.47 | 3.92 |
| Price-to-Operating Cash Flow Ratio | 2.66 | 4.08 | 4.61 | 8.27 | 3.14 |
| Price-to-Earnings Growth (PEG) Ratio | -0.13 | -0.27 | 0.32 | -0.24 | -0.15 |
| Enterprise Value Multiple | 7.82 | 7.60 | 8.30 | 8.83 | 8.25 |
| Enterprise Value | 10.09B | 12.20B | 11.92B | 15.50B | 16.35B |
| EV to EBITDA | 7.82 | 7.60 | 8.30 | 8.83 | 8.25 |
| EV to Sales | 1.62 | 1.90 | 1.90 | 2.51 | 2.59 |
| EV to Free Cash Flow | 18.75 | 20.74 | 22.15 | 35.97 | 8.30 |
| EV to Operating Cash Flow | 14.41 | 12.99 | 14.92 | 18.07 | 6.65 |
| Tangible Book Value Per Share | -17.46 | -21.87 | -20.40 | -24.18 | -26.67 |
| Shareholders’ Equity Per Share | 2.90 | 1.84 | -0.27 | -3.51 | -5.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.56 | -0.07 | -0.52 | 0.18 | 0.12 |
| Revenue Per Share | 23.95 | 24.91 | 24.54 | 24.30 | 24.86 |
| Net Income Per Share | 0.72 | 3.36 | 4.01 | 3.61 | 5.33 |
| Tax Burden | 0.44 | 1.07 | 1.52 | 0.82 | 0.88 |
| Interest Burden | 0.46 | 0.61 | 0.56 | 0.73 | 0.86 |
| Research & Development to Revenue | 0.06 | 0.07 | 0.08 | 0.08 | 0.07 |
| SG&A to Revenue | 0.28 | 0.27 | 0.27 | 0.23 | 0.23 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| Income Quality | 3.74 | 1.09 | 0.78 | 0.94 | 1.82 |
Currency in USD
